Fluphenazine Decanoate Injection, Solution
Product Images NDC 55150-267

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fluphenazine Decanoate (NDC 55150-267). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (125 mg per 5 mL (25 mg / mL))

Fluphenazine Decanoate is an injection intended for intramuscular or subcutaneous use. Each 5mL vial contains 125 mg of fluphenazine decanoate USP, equivalent to 18.5 mg of fluphenazine, which is a drug commonly used to treat psychotic disorders. It also includes benzyl alcohol as a preservative and sesame oil. The recommended dose is indicated in the insert, and it should be stored at a temperature between 20-25°C (68-77°F) protected from light. The product is manufactured by Auromedics Pharma LLC and has the NDC 55150-267-05 code.*

FDA Label Image

Package Label-principal Display Panel (125 mg per 5 mL (25 mg / mL))

This is a description of a medication called Fluphenazine Decanoate Injection, USP manufactured by AuroMesics Pharma. It comes in a 5mL multiple dose vial with a concentration of 125mg per 5 mL (25mg/mL). It is intended for intramuscular or subcutaneous use and must be stored at controlled room temperature between 20 and 25 degrees Celsius. The medication is used to treat psychotic disorders. The text also includes prescription and distribution information.*

FDA Label Image

Fluphenazine Decanoate Chemical Structure (Fluphenazine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.